兆科眼科 2025 年上半年营收1580万元,已有三款核心药物进入新药申请阶段

动脉网
Aug 29

(原标题:兆科眼科 2025 年上半年营收1580万元,已有三款核心药物进入新药申请阶段)8 月 28 日,兆科眼科发布了其2025年中期业绩, 2025 年上半年的收入约 1580 万元;撇除去年同期根据产品许可协议确认的3350 万元的一次性许可收入,公司今年上半年来自药物和产品的收入约为 1,510 万元,与 2024 年同期之人民币 1,560 万元相比录得轻微跌幅。2025 年上半年...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10